| Literature DB >> 33536494 |
Ryo Amano1, Masato Namekata2, Masataka Horiuchi3, Minami Saso1, Takuya Yanagisawa1, Yoichiro Tanaka4, Farhana Ishrat Ghani2, Masakuni Yamamoto2, Taiichi Sakamoto5.
Abstract
Fibroblast growth factor 5 (FGF5) is a crucial regulator of hair growth and an oncogenic factor in several human cancers. To generate FGF5 inhibitors, we performed Systematic Evolution of Ligands by EXponential enrichment and obtained novel RNA aptamers that have high affinity to human FGF5. These aptamers inhibited FGF5-induced cell proliferation, but did not inhibit FGF2-induced cell proliferation. Surface plasmon resonance demonstrated that one of the aptamers, F5f1, binds to FGF5 tightly (Kd = 0.7 ± 0.2 nM), but did not fully to FGF1, FGF2, FGF4, FGF6, or FGFR1. Based on sequence and secondary structure similarities of the aptamers, we generated the truncated aptamer, F5f1_56, which has higher affinity (Kd = 0.118 ± 0.003 nM) than the original F5f1. Since the aptamers have high affinity and specificity to FGF5 and inhibit FGF5-induced cell proliferation, they may be candidates for therapeutic use with FGF5-related diseases or hair disorders.Entities:
Year: 2021 PMID: 33536494 DOI: 10.1038/s41598-021-82350-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379